LPL Financial
LPLA
324.80
-7.59
-2.28%
LPL Financial
US · LPLA
#815 by market cap
Listed 1970
324.80
-7.59
-2.28%
Live - 5344 symbols - heartbeat 378s ago
· 2026-10-08 07:40
Pre-market
324.80
0.00%
After-hours
324.80
0.00%
- Market cap
- 25.58B
- P/E (TTM)i
- 26.03
- P/Bi
- 4.44
- EPSi
- 10.92
- Div yieldi
- 0.37%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on LPLA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +37.18% YoY
Margins
- Gross margin
- 23.67%
- Operating margin
- 9.14%
- Net margin
- 5.08%
Key ratios & quality
- Enterprise valuei
- 31.72B
- PEG ratioi
- 38.38
- Altman Z-Scorei
- 3.14
PEG uses trailing P/E against the 3-year net income growth rate (0.68%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.19B | 5.62B | 5.87B | 7.72B | 8.60B | 10.05B | 12.39B | 16.99B |
| Gross profit | 1.44B | 1.62B | 1.49B | 1.71B | 2.37B | 3.05B | 3.37B | 4.02B |
| Selling & admin expenses | 456.17M | 465.45M | 484.11M | 621.34M | 700.00M | 856.15M | 1.04B | 1.62B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 717.66M | 874.99M | 731.84M | 730.14M | 1.24B | 1.63B | 1.67B | 1.55B |
| Pretax profit | 592.64M | 741.84M | 626.07M | 601.33M | 1.11B | 1.44B | 1.39B | 1.15B |
| Tax | 153.18M | 181.96M | 153.43M | 141.46M | 265.95M | 378.53M | 334.28M | 286.48M |
| Net profit | 439.46M | 559.88M | 472.64M | 459.87M | 845.70M | 1.07B | 1.06B | 863.02M |
| Basic EPS | 5 | 7 | 6 | 6 | 11 | 14 | 14 | 11 |
| Diluted EPS | 4.85 | 6.62 | 5.86 | 5.63 | 10.40 | 13.69 | 14.03 | 10.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.67B | 3.84B | 4.55B | 4.93B | 4.94B | 5.19B |
| Gross profit | 966.40M | 989.47M | 898.01M | 1.17B | 1.22B | 1.27B |
| Selling & admin expenses | 278.72M | 321.50M | 606.79M | 411.99M | 400.77M | 422.53M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 503.12M | 474.44M | 72.18M | 503.17M | 584.88M | 617.01M |
| Pretax profit | 417.25M | 368.80M | -34.11M | 397.56M | 484.58M | 515.50M |
| Tax | 98.68M | 95.56M | -4.59M | 96.84M | 128.18M | 136.24M |
| Net profit | 318.57M | 273.25M | -29.52M | 300.72M | 356.40M | 379.26M |
| Basic EPS | 4 | 3 | 0 | 4 | 4 | 5 |
| Diluted EPS | 4.24 | 3.40 | -0.37 | 3.74 | 4.43 | 4.74 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.72B | 2.89B | 3.45B | 4.45B | 5.74B | 5.69B | 6.84B | 9.18B |
| Cash & ST investments | 520.76M | 616.16M | 818.36M | 514.92M | 884.28M | 541.76M | 1.01B | 1.11B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 5.48B | 5.88B | 6.60B | 7.99B | 9.48B | 10.39B | 13.32B | 18.49B |
| Total current liabilities | 1.72B | 1.90B | 2.22B | 2.74B | 3.63B | 3.57B | 4.19B | 3.99B |
| Short-term debt | -- | 45.00M | -- | 90.00M | -- | 280.00M | 1.05B | 79.00M |
| Long-term debt | 2.37B | 2.35B | 2.35B | 2.72B | 2.72B | 3.45B | 4.45B | 7.18B |
| Total liabilities | 4,503,395,000.00 | 4,856,365,000.00 | 5,281,308,000.00 | 6,321,067,000.00 | 7,314,674,000.00 | 8,306,501,000.00 | 10,386,802,000.00 | 13,148,268,000.00 |
| Total equity | 974.07M | 1.02B | 1.31B | 1.67B | 2.17B | 2.08B | 2.93B | 5.34B |
| Retained earnings | 1.07B | 1.55B | 1.94B | 2.33B | 3.10B | 4.09B | 5.07B | 5.84B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 7.34B | 10.58B | 8.78B | 9.18B | 9.32B | 9.94B |
| Cash & ST investments | 1.35B | 4.31B | 1.54B | 1.11B | 1.11B | 1.46B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 13.96B | 17.47B | 18.03B | 18.49B | 18.84B | 19.79B |
| Total current liabilities | 3.35B | 3.49B | 3.93B | 3.99B | 3.86B | 4.65B |
| Short-term debt | -- | -- | 344.00M | 79.00M | -- | 276.00M |
| Long-term debt | 5.69B | 7.18B | 7.18B | 7.18B | 7.18B | 7.18B |
| Total liabilities | 10,839,439,000.00 | 12,399,260,000.00 | 12,989,276,000.00 | 13,148,268,000.00 | 13,149,539,000.00 | 14,034,280,000.00 |
| Total equity | 3.12B | 5.07B | 5.04B | 5.34B | 5.69B | 5.76B |
| Retained earnings | 5.37B | 5.62B | 5.57B | 5.84B | 6.17B | 6.52B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 581.58M | 623.87M | 789.94M | 453.13M | 1.95B | 512.61M | 277.59M | -411.40M |
| Depreciation & amortization | 147.91M | 161.11M | 177.09M | 230.69M | 287.38M | 354.21M | 443.76M | 630.01M |
| Free cash flow | 448.89M | 467.48M | 634.41M | 237.15M | 1.64B | 109.33M | -284.94M | -981.78M |
| Dividends paid | -88.36M | -82.60M | -79.10M | -80.10M | -79.83M | -92.19M | -89.73M | -94.41M |
| Stock buybacks / issuance | -417.89M | -500.37M | -150.04M | -90.01M | -325.03M | -1.10B | -170.10M | 1.62B |
| Ending cash balance | 1.56B | 1.47B | 1.80B | 2.07B | 3.14B | 2.58B | 2.68B | 3.05B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 339.81M | 193.30M | -1.73B | 785.01M | 290.40M | 401.95M |
| Depreciation & amortization | 135.88M | 142.33M | 164.43M | 187.37M | 172.98M | 180.69M |
| Free cash flow | 220.34M | 56.31M | -1.87B | 613.33M | 124.64M | 202.51M |
| Dividends paid | -22.39M | -24.00M | -24.01M | -24.02M | -24.06M | -23.97M |
| Stock buybacks / issuance | -100.24M | 1.73B | 0 | 0 | 0 | -309.48M |
| Ending cash balance | 2.85B | 5.91B | 2.82B | 3.05B | 2.91B | 2.93B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 45.33 | 56.05 | 40.42 | 30.81 | 44.07 | 50.22 | 42.26 | 20.86 |
| ROA %i | 8.11 | 9.86 | 7.62 | 6.34 | 9.68 | 10.73 | 8.93 | 5.43 |
| ROIC %i | 15.41 | 18.47 | 14.58 | 12.38 | 19.32 | 21.05 | 17.21 | 10.85 |
| 5-year avg ROE %i | 26.85 | 34.62 | 38.70 | 39.87 | 43.33 | 44.31 | 41.56 | 37.64 |
| EBIT margin %i | 13.83 | 15.50 | 12.46 | 9.14 | 14.39 | 16.23 | 13.46 | 9.14 |
| FCF / sales %i | 8.11 | 8.31 | 10.80 | 3.07 | 19.06 | 1.09 | -- | -- |
| Current ratioi | 1.59 | 1.52 | 1.56 | 1.63 | 1.58 | 1.60 | 1.63 | 2.30 |
| Quick ratioi | 0.96 | 1.04 | 1.06 | 1.00 | 0.91 | 0.95 | 1.17 | 1.74 |
| Debt / assetsi | 45.21 | 45.05 | 39.30 | 38.17 | 31.09 | 38.16 | 43.16 | 40.35 |
| LT debt / equityi | 254.23 | 254.36 | 197.15 | 177.21 | 136.02 | 177.16 | 160.40 | 138.15 |
| Interest coveragei | 5.74 | 6.71 | 6.92 | 6.76 | 9.81 | 8.73 | 6.08 | 3.85 |
| Revenue CAGR (3Y) %i | 6.67 | 11.58 | 11.10 | 14.17 | 15.21 | 19.63 | 17.06 | 25.47 |
| Net income CAGR (3Y) %i | 37.57 | 42.88 | 25.54 | 1.52 | 14.74 | 31.15 | 32.04 | 0.68 |
| FCF CAGR (3Y) %i | 29.46 | 21.40 | 22.94 | -19.16 | 51.92 | -44.35 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 40.36 | 29.46 | 21.32 | 20.86 | 20.45 | 18.59 |
| ROA %i | 8.71 | 7.72 | 5.56 | 5.43 | 5.49 | 5.40 |
| ROIC %i | 17.51 | 14.05 | 10.93 | 10.85 | 10.91 | 10.04 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.13 | 12.86 | 9.46 | 9.14 | 8.95 | 9.06 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.19 | 3.03 | 2.24 | 2.30 | 2.41 | 2.14 |
| Quick ratioi | 1.64 | 2.48 | 1.81 | 1.74 | 1.86 | 1.73 |
| Debt / assetsi | 42.67 | 42.00 | 42.74 | 40.35 | 39.36 | 38.83 |
| LT debt / equityi | 190.73 | 144.62 | 146.01 | 138.15 | 130.38 | 128.71 |
| Interest coveragei | 5.79 | 5.32 | 3.88 | 3.85 | 3.91 | 4.30 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Advisory is the largest reported line at 50.75% of revenue, across 9 reported segments.
- Annuities follows at 14.03%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Advisory50.75%
Annuities14.03%
Client cash8.55%
Other5.22%
Mutual Funds5.05%
Sponsorship programs4.54%
Service and fee4.03%
Recordkeeping3.01%
Commission revenue - Other1.96%
Quote time 2026-10-08 07:40:45 · For reference only, not investment advice and not tailored to your situation.